A 19-year-old woman who acquired HIV at birth is seen for a routine medical visit with her HIV primary care provider. She is taking an antiretroviral regimen of tenofovir alafenamide-emtricitabine plus darunavir-cobicistat. Recent laboratory studies showed a CD4 count of 512 cells/mm³ and an undetectable HIV RNA level. A little more than one year ago, she became sexually active with a single male partner. For the past year, she has been sexually active with a single male partner. She has completed the human papillomavirus (HPV) vaccine series.